logo
IndusInd Bank, Hero MotoCorp may exit Nifty to make way for IndiGo, Max Healthcare: Nuvama

IndusInd Bank, Hero MotoCorp may exit Nifty to make way for IndiGo, Max Healthcare: Nuvama

Economic Times11 hours ago
Live Events
Will BSE make it to Nifty?
(You can now subscribe to our
(You can now subscribe to our ETMarkets WhatsApp channel
Crisis-ridden IndusInd Bank and two-wheeler major Hero MotoCorp may be excluded from the Nifty50 in the upcoming reshuffle due in September, according to calculations by Nuvama Alternative and Quantitative Research.The firm identified IndiGo and Max Healthcare as the top two inclusion candidates. "IndiGo has already seen substantial positive price action, reflecting market expectations. On the other hand, Max Healthcare appears under-owned on this theme and could attract more buying interest. We estimate that Max Health's inclusion would imply passive buying of over $400 million (approximately 12 days of average daily volume)," the brokerage said.Conversely, Hero MotoCorp and IndusInd Bank are likely to be excluded from the Nifty50, potentially facing passive outflows of $244 million and $255 million, respectively. The cut-off period for eligibility ends in July, with the official announcement expected in late August and adjustments implemented on September 29.'While much of the negative sentiment appears to be priced in, we believe any further downside will be more pronounced around the adjustment period. Until then, we don't expect significant pressure purely from expected passive flows,' Nuvama said.The only scenario in which Max Healthcare may miss inclusion is if Hindustan Aeronautics (HAL) outperforms Max Health by approximately 12% immediately and sustains that outperformance through the end of July. Nuvama added that this is a low-probability event.While earlier media reports suggested that stock exchange BSE could be included in the Nifty50 in the September rejig, Nuvama has ruled out any possibility of that happening, at least in the September 2025 review.'We've gone through the methodology document in detail, and our understanding suggests that BSE fails to meet several key eligibility criteria. In fact, we believe there's almost no chance of BSE even making it to the Nifty Next 50 in the September 2025 review,' it said.However, an inclusion could become possible if the index construction methodology changes or if BSE shares rise sharply — by over 40% — and sustain that rally through the end of July.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Noel Tata talks up Trent's grocery business as its next big Star
Noel Tata talks up Trent's grocery business as its next big Star

Mint

timean hour ago

  • Mint

Noel Tata talks up Trent's grocery business as its next big Star

Bengaluru: Trent Ltd's grocery business, Star, holds the potential to become larger than the Tata Group-backed company's flagship fashion brands Zudio and Westside, chairman Noel Tata said on Thursday. 'This is only because the food market is much bigger than the market for clothing,' Tata said addressing shareholders at Trent's annual general meeting. 'So, we are convinced there's a huge opportunity there and with time you will see that we will deliver a big business in the food and grocery space as well.' Trent ended Thursday's trading session with a market capitalisation of ₹ 2,19,918.76 crore, which makes it the Tata Group's fourth-most valuable company, behind Tata Consultancy Services Ltd, Titan Co. Ltd, andTata Motors Ltd. Trent's focus on Star comes less than a year after Noel Tata's son Neville Tata, 32, was appointed as the business head of the grocery business. Star has accumulated over ₹ 1,000 crore in losses over the previous six years. Zudio, meanwhile, crossed the ₹ 8,300 crore revenue mark in 2024-25, while Westside generated ₹ 6,210 crore in revenue. Star, however, contributed about 15.2% to Trent's consolidated revenue in FY25, underscoring its growing weight in the company's overall portfolio. Star recorded its highest-ever revenue of ₹ 8,854 crore during the year, up nearly 25% from FY24. According to an analyst report by HDFC Securities Ltd, Trent plans to invest ₹ 2,000 crore in Trent Hypermarket Pvt. Ltd, which runs Star, this financial year. That would be nearly three times the ₹ 754 crore Trent has invested in its grocery business in nearly two decades, the brokerage firm said in a note dated June 27. Neol Tata did not comment on this at the AGM. Trent did not immediately reply to Mint's emailed queries. Trent shares ended Thursday's trading on NSE down 0.68% at ₹ 6,180.00 each, while the benchmark Nifty 50 index shed 0.19%. Trent's Star format store has prioritised focus on building in-house or private-label products. In the fourth quarter of FY25, private-label products accounted for 72% of Star's sales. Fresh produce and general merchandise together accounted for 50.5% of Star's product mix during the quarter. 'They (Star) are not growing aggressively at the moment,' said Pratik Prajapati, equity research analyst at financial advisory Ambit. 'The priority is chasing growth and making existing stores profitable before expanding further.' Trent's ambition for Star, however, comes at a time when quick-commerce firms likeSwiggy's Instamart, Zomato's Blinkit, and Zepto are upending how people, particularly in large cities, buy groceries. 'The format (Star) is facing tough competition in these markets, where speed and convenience are becoming as important as price,' said Prajapati. According to a February report by PwC and Hansa Research, quick-commerce in India grew at 73% in FY24, with over 90% of its demand concentrated in India's top eight cities. Blinkit, Zepto, and Instamart have made significant inroads in metropolitan cities, where 42% of consumers prefer instant deliveries for essentials such as packaged food and personal care products, it said. Noel Tata, who is credited with building Zudio and Westside, was appointed chair of Tata Trusts in October following the passing of Ratan Tata. Tata Trusts is the umbrella entity that oversees the functioning of all the philanthropic entities of Tatas, including the seven Tata Trusts that together own 65.9% of Tata Sons. Tata Sons, headed by chairman Natarajan Chandrasekaran, is the group's operating company and owns shares in 26 Tata companies, including Trent, TCS, and Tata Motors.

Carlyle Group may sell 10% stake in Piramal Pharma via block deals: Report
Carlyle Group may sell 10% stake in Piramal Pharma via block deals: Report

Business Standard

timean hour ago

  • Business Standard

Carlyle Group may sell 10% stake in Piramal Pharma via block deals: Report

United States-based private equity firm Carlyle Group is planning to divest up to 10 per cent stake in Piramal Pharma through block deals, Moneycontrol reported on Thursday, citing sources. The sale could amount to ₹2,600-2,700 crore, the report added. Piramal Pharma sold 20 per cent of its stake to Carlyle Group in June 2020, in a deal worth ₹3,523 crore. According to stock exchange data, it held 18 per cent stake in the pharma firm as of March 31, 2025. Financial services firm Motilal Oswal has been roped in to facilitate the block deals, the report added. Piramal Pharma operates a diverse and global pharmaceutical business, providing a broad range of products and services. It includes Piramal Pharma Solutions (PPS), a fully integrated contract development and manufacturing organisation (CDMO); Piramal Critical Care (PCC), a complex hospital generics business; and the India Consumer Healthcare business, selling over-the-counter consumer and wellness products. Piramal Pharma Q4 result In the fourth quarter of FY25, Piramal Pharma posted a consolidated revenue from operations of ₹2,754 crore, marking an 8 per cent increase over the ₹2,552 crore recorded in the same quarter last year. The company's EBITDA (earnings before interest, tax, depreciation, and amortisation) also increased by 8 per cent year-on-year to ₹603 crore, up from ₹556 crore. Profit after tax (before exceptional items) came in at ₹154 crore, reflecting a 16 per cent rise compared to ₹132 crore in the corresponding period of the previous financial year. Shares of Piramal Pharma last traded at ₹202.4 apiece on the BSE at the close of the markets on Thursday.

Brokerages remain cautious on Asian Paints despite recent rally in stock
Brokerages remain cautious on Asian Paints despite recent rally in stock

Business Standard

time2 hours ago

  • Business Standard

Brokerages remain cautious on Asian Paints despite recent rally in stock

Shares of Asian Paints rose to a two-month high, but brokerages remain cautious amid regulatory scrutiny and growing competition in the premium segment Deepak Korgaonkar Mum Listen to This Article Shares of the largest Indian paint company, Asian Paints, hit a two-month high of ₹2,464, up 2 per cent on the BSE in Thursday's intra-day trade amid heavy volumes. The stock price of the paint company has bounced back nearly 5 per cent from Wednesday's low, shrugging off the probe by the Competition Commission of India (CCI). The stock, which has outperformed the Nifty50 over the past month by delivering 7.8 per cent returns compared to 3.5 per cent for the benchmark, ended the day a tad higher. The Competition Commission of India (CCI) has ordered its director general (DG)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store